The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma.

[1]  V. Diehl,et al.  Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. , 1993, The American journal of pathology.

[2]  G. V. Vande Woude,et al.  Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. , 1992, Blood.

[3]  G. V. Vande Woude,et al.  Evidence for non-covalent clusters of the c-met proto-oncogene product. , 1992, Oncogene.

[4]  V. Diehl,et al.  Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. , 1992, Oncogene.

[5]  M. Tsao,et al.  Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. , 1992, Oncogene.

[6]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[7]  C. von Kalle,et al.  Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. , 1991, Blood.

[8]  G. Wogan,et al.  The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[10]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[11]  V. Diehl,et al.  Heterogeneous expression of proto‐oncogenes in Hodgkin's disease derived cell lines , 1990, Hematological oncology.

[12]  T. Nakamura,et al.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Andreeff,et al.  Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. , 1990, Cancer research.

[14]  G. Michalopoulos,et al.  Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. V. Vande Woude,et al.  Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  J. Rhim,et al.  TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Cooper,et al.  Biosynthesis of the protein encoded by the c-met proto-oncogene. , 1989, Oncogene.

[18]  C. Cooper,et al.  Tyrosine kinase receptor indistinguishable from the c-met protein , 1989, Nature.

[19]  G. Bornkamm,et al.  Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc , 1989, Molecular and cellular biology.

[20]  H. Drexler,et al.  Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines. , 1988, Leukemia.

[21]  V. Diehl,et al.  Immunologic, functional and moleculargenetic properties of Hodgkin-derived cell lines , 1988 .

[22]  G. V. Vande Woude,et al.  Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Julier,et al.  Detection of a NotI polymorphism with the pmetH probe by pulsed-field gel electrophoresis. , 1988, American journal of human genetics.

[24]  M. Braun,et al.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  V. Diehl,et al.  Phenotype versus immunoglobulin and T‐cell receptor genotype of Hodgkin‐derived cell lines: Activation of immature lymphoid cells in Hodgkin's disease , 1987, International journal of cancer.

[26]  H. Lehrach,et al.  Derivation of clones close to met by preparative field inversion gel electrophoresis. , 1987, Science.

[27]  C. Cooper,et al.  Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. , 1986, The EMBO journal.

[28]  C. Cooper,et al.  Mechanism of met oncogene activation , 1986, Cell.

[29]  V. Diehl,et al.  Cytogenetic investigations in Hodgkin's disease: I. Involvement of specific chromosomes in marker formation. , 1986, Cancer genetics and cytogenetics.

[30]  K. C. Reed,et al.  Rapid transfer of DNA from agarose gels to nylon membranes. , 1985, Nucleic acids research.

[31]  G. Lenoir,et al.  The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. , 1985, IARC scientific publications.

[32]  J. Rowley,et al.  The human met oncogene is related to the tyrosine kinase oncogenes , 1985, Nature.

[33]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[34]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[36]  V. Diehl,et al.  Translocation t(8;22) in peripheral lymphocytes and established lymphoid cell lines from a patient with Hodgkin's disease followed by acute lymphatic leukemia , 1982, International journal of cancer.

[37]  R. Berger,et al.  Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma , 1982, Nature.

[38]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[39]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[40]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[41]  H. Lazarus,et al.  Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia , 1965, Cancer.